SUGATAB® – G1 / G2 Tablet

SUGATAB® – G1 / G2 contains Glimepiride, a second-generation sulfonylurea that helps manage blood sugar in adults with type 2 diabetes mellitus (T2DM). It works by stimulating the pancreas to release insulin, thereby improving blood sugar utilization. It is ideal for patients who require insulin secretagogue therapy, especially in combination with metformin or lifestyle interventions.

Categories: ,

Description

Composition (Each Film-Coated Tablet Contains):

  • SUGATAB® – G1: Glimepiride 1 mg

  • SUGATAB® – G2: Glimepiride 2 mg

Category: Diabetes Care / Sulfonylurea Monotherapy
Form: Oral Tablet
Pack Size: 10×10 Alu-Alu or Blister Pack


Product Description:

SUGATAB® – G1 / G2 contains Glimepiride, a second-generation sulfonylurea that helps manage blood sugar in adults with type 2 diabetes mellitus (T2DM). It works by stimulating the pancreas to release insulin, thereby improving blood sugar utilization. It is ideal for patients who require insulin secretagogue therapy, especially in combination with metformin or lifestyle interventions.


Key Benefits:

  • Enhances insulin release from functioning beta cells

  • Reduces both fasting and post-meal blood glucose

  • Long-acting action supports once-daily dosing

  • Suitable for step-up therapy with metformin

  • Available in multiple strengths for flexible titration


How it works:

Glimepiride binds to sulfonylurea receptors on pancreatic beta cells, stimulating the release of insulin in a glucose-dependent manner. This improves peripheral glucose uptake and lowers circulating blood sugar levels. Its long half-life supports sustained action throughout the day.


How to use:

  • Take once daily, preferably with breakfast or the first main meal

  • Swallow the tablet whole with water — do not chew or break

  • Dosage may be adjusted by your physician based on glucose monitoring

  • Avoid skipping meals after taking the tablet


Safety Advice:

  • May cause hypoglycemia, especially if meals are missed — carry a sugar source if needed

  • Monitor blood glucose levels regularly

  • Avoid alcohol while on sulfonylurea therapy

  • Inform your doctor if you experience symptoms like sweating, tremors, or dizziness


Precautions:

  • Not for use in type 1 diabetes, DKA, or severe hepatic/renal impairment

  • Use cautiously in elderly or malnourished patients

  • Not recommended during pregnancy or breastfeeding without physician supervision

  • Inform your doctor of all concurrent antidiabetic medications or insulin


Storage:

Store below 25°C in a dry place.
Protect from sunlight and moisture.
Keep out of reach of children.

Reviews

There are no reviews yet.

Be the first to review “SUGATAB® – G1 / G2 Tablet”

Your email address will not be published. Required fields are marked *